OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Revenue

OliX Pharmaceuticals had revenue of 2.62B KRW in the quarter ending June 30, 2026, a decrease of -58.02%. This brings the company's total for the last twelve months to 13.64B, up 80.93% year-over-year. In the year 2025, OliX Pharmaceuticals had annual revenue of 14.67B with 158.35% growth. That makes OliX Pharmaceuticals the 37,299th largest company in the world by revenue and 2,378th in South Korea.

• Revenue (ttm): 13.64B
• Revenue Growth: +80.93%
• P/S Ratio: 156.83
• Revenue / Employee: 168.35M
• Employees: 81
• Market Cap: 2.10T

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	14.67B	8.99B	158.35%
Dec 31, 2024	5.68B	-11.39B	-66.73%
Dec 31, 2023	17.06B	7.74B	83.09%
Dec 31, 2022	9.32B	5.65B	153.66%
Dec 31, 2021	3.67B	1.20B	48.50%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error